Wolfson Institute of Preventive Medicine - Barts and The London

Publications

AuthorsPublication SummaryJournalYears
Wald N,Wald D,Kellermann AL When Guidelines Cause Hypertension.. vol.131, (12) 1402.
10.1016/j.amjmed.2018.06.007
Am J Med 2018
Wald NJ,Bestwick J,Huttly W,Aldis J,Borrell A,Goodburn S,Mills I Prenatal screening for Down syndrome in twin pregnancies: estimates of screening performance based on 61 affected and 7,302 unaffected twin pregnancies.. vol.volume, (issue) paginationBegin.
10.1002/pd.5381
Prenat Diagn 2018
WALD D,WALD NJ Integration of child-parent screening and cascade testing for familial hypercholesterolaemia. vol.volume, (issue) paginationBegin.
10.1177/0969141318796856
Journal of Medical Screening 2018
WALD NJ,LAU KW,BESTWICK J,Old R,HUTTLY W,CHENG R Specifying a Gold-Standard for the validation of fetal fraction estimation in prenatal screening. vol.64, (9) 1394.
10.1373/clinchem.2018.288670
Clinical Chemistry 2018
BESTWICK JP,HUTTLY W,WALD N Serum marker truncation limits in first trimester antenatal screening for trisomy 18. vol.volume, (issue) paginationBegin.
10.1177/0969141318783021
Journal of Medical Screening 2018
Wald NJ Prenatal reflex DNA screening for trisomy 21, 18 and 13.. vol.18, (5) 399.
10.1080/14737159.2018.1462703
Expert Rev Mol Diagn 2018
Wald NJ,Huttly WJ,Bestwick JP,Old R,Morris JK,Cheng R,Aquilina J,Peregrine E,Roberts D,Alfirevic Z Response to Walker.. vol.volume, (issue) paginationBegin.
10.1038/gim.2017.256
Genet Med 2018
WALD NJ,MORRIS J,Blakemore C Public health failure in the prevention of neural tube defects: time to abandon the Tolerable Upper Intake Level of folate. vol.39, (2) paginationBegin.
10.1186/s40985-018-0079-6
Public Health Reviews 2018
Wald NJ,Old R Conflating screening detection rates with the uptake of further testing: A potential source of confusion. vol.volume, (issue) paginationBegin.
10.1177/0969141318781675
Journal of Medical Screening 2018
Wald NJ Screening and preventive medication.. vol.24, (4) 169.
10.1177/0969141316650712
J Med Screen 2017
WALD NJ,Huttly WJ,Bestwick JP,Old R,Morris JK,Cheng R,Aquilina J,Peregrine E,Roberts D,Alfirevic Z Prenatal reflex DNA screening for trisomy 21, 18, and 13. vol.volume, (issue) paginationBegin.
10.1038/gim.2017.188
Genetics in Medicine 2017
Old RW,Bestwick JP,WALD NJ Prenatal maternal plasma DNA screening for cystic fibrosis: A computer modelling study of screening performance. vol.volume, (issue) paginationBegin.
10.12688/f1000research.12849.1
F1000Research 2017
Wald N Sharing Clinical Trial Data.. vol.24, (2) 57.
10.1177/0969141316646604
J Med Screen 2017
Sasieni PD,Wald NJ Should a Reduction in All-Cause Mortality Be the Goal When Assessing Preventive Medical Therapies?. vol.135, (21) 1985.
10.1161/CIRCULATIONAHA.116.023359
Circulation 2017
Wald NJ,Wald DS Blood pressure and cardiovascular outcomes: a closer look.. vol.389, (10076) 1296.
10.1016/S0140-6736(17)30834-6
Lancet 2017
WALD D,Bangash F,Morris J,Wald N Mortality from aortic stenosis – prospective study of serum calcium and phosphate. vol.281, (4) 407.
10.1111/joim.12593
Journal of Internal Medicine 2017
Wald NJ,Morris JK The Need to Interpret the Results of a Clinical Trial in the Context of Other Evidence.. vol.130, (3) 251.
10.1016/j.amjmed.2016.08.015
Am J Med 2017
Wald DS,Bestwick JP,Wald NJ Child-Parent Familial Hypercholesterolemia Screening in Primary Care.. vol.376, (5) 499.
10.1056/NEJMc1615365
N Engl J Med 2017
Bestwick JP,Huttly WJ,Wald NJ Pregnancy-associated plasma protein-A truncation limits in antenatal screening for trisomy 18.. vol.volume, (issue) 969141316688499.
10.1177/0969141316688499
J Med Screen 2017
Bestwick JP,Wald NJ Antenatal reflex DNA screening for trisomy 18 and trisomy 13 in addition to Down's syndrome.. vol.23, (4) 171.
10.1177/0969141315617982
J Med Screen 2016
Wald NJ The Limited Public Health Impact of 'Lifestyle' Change.. vol.129, (12) 1236.
10.1016/j.amjmed.2016.06.033
Am J Med 2016
Lee JW,Morris JK,Wald NJ The Reply.. vol.129, (11) e303.
10.1016/j.amjmed.2016.06.032
Am J Med 2016
Wald N,Law M Sodium and cardiovascular disease.. vol.388, (10056) 2111.
10.1016/S0140-6736(16)31909-2
Lancet 2016
WALD D,Bestwick J,Morris J,Whyte K,Jenkins L,Wald N Child-Parent Familial Hypercholesterolemia Screening in Primary Care. vol.375, (17) 1628.
10.1056/NEJMoa1602777
New England Journal of Medicine 2016
Collins R,Reith C null,Emberson J,Armitage J,Baigent C null,Blackwell L,Blumenthal R,Danesh J,Davey Smith G,DeMets D,Evans S,Law MR,MacMahon S,Martin S,Neal B,Poulter N,Preiss D,Ridker P,Roberts I,Rodgers A,Sandercock P,Schulz K,Sever P,Simes J,Smeeth L,Wald NJ,Yusuf S,Peto R Interpretation of the evidence for the efficacy and safety of statin therapy. vol.volume, (issue) paginationBegin.
10.1016/S0140-6736(16)31357-5
Lancet 2016
Wald NJ,Oppenheimer P Discounting financial costs and health benefits in public health programmes.. vol.23, (3) 115.
10.1177/0969141315626190
J Med Screen 2016
Bestwick JP,Wald NJ Sequential integrated antenatal screening for Down's syndrome, trisomy 18 and trisomy 13.. vol.23, (3) 116.
10.1177/0969141315608895
J Med Screen 2016
Morris JK,Rankin J,Draper ES,Kurinczuk JJ,Springett A,Tucker D,Wellesley D,Wreyford B,Wald NJ Prevention of neural tube defects in the UK: a missed opportunity.. vol.101, (7) 604.
10.1136/archdischild-2015-309226
Arch Dis Child 2016
Luteijn M,Wald NJ The NHS Health Checks programme: A better alternative.. vol.23, (2) 57.
10.1177/0969141315621772
J Med Screen 2016
Field JK,Duffy SW,Baldwin DR,Brain KE,Devaraj A,Eisen T,Green BA,Holemans JA,Kavanagh T,Kerr KM,Ledson M,Lifford KJ,McRonald FE,Nair A,Page RD,Parmar MKB,Rintoul RC,Screaton N,Wald NJ,Weller D,Whynes DK,Williamson PR,Yadegarfar G,Hansell DM The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. vol.20, (40) 1.
10.3310/hta20400
Health Technology Assessment 2016
Travis RC,Appleby PN,Martin RM,Holly JMP,Albanes D,Black A,Bueno-de-Mesquita HBA,Chan JM,Chen C,Chirlaque M-D,Cook MB,Deschasaux M,Donovan JL,Ferrucci L,Galan P,Giles GG,Giovannucci EL,Gunter MJ,Habel LA,Hamdy FC,Helzlsouer KJ,Hercberg S,Hoover RN,Janssen JAMJL,Kaaks R,Kubo T,Le Marchand L,Metter EJ,Mikami K,Morris JK,Neal DE,Neuhouser ML,Ozasa K,Palli D,Platz EA,Pollak M,Price AJ,Roobol MJ,Schaefer C,Schenk JM,Severi G,Stampfer MJ,Stattin P,Tamakoshi A,Tangen CM,Touvier M,Wald NJ,Weiss NS,Ziegler RG,Key TJ,Allen NE A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk.. vol.76, (8) 2288.
10.1158/0008-5472.CAN-15-1551
Cancer Res 2016
Wald NJ,Luteijn JM,Morris JK,Taylor D,Oppenheimer P Cost-benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke.. vol.31, (4) 415.
10.1007/s10654-016-0122-1
Eur J Epidemiol 2016
Wald NJ,Bestwick JP Prenatal reflex DNA screening for Down syndrome: enhancing the screening performance of the initial first trimester test.. vol.36, (4) 328.
10.1002/pd.4784
Prenat Diagn 2016
Wald NJ,Bestwick JP Antenatal reflex DNA screening for Down's syndrome using total instead of free B-hCG in the Combined test.. vol.23, (1) 50.
10.1177/0969141315607545
J Med Screen 2016
Huttly WJ,Bestwick JP,Wald NJ Insulin dependent diabetes mellitus (IDDM) and first trimester markers in prenatal screening for Down syndrome.. vol.36, (2) 192.
10.1002/pd.4722
Prenat Diagn 2016
Field JK,Duffy SW,Baldwin DR,Whynes DK,Devaraj A,Brain KE,Eisen T,Gosney J,Green BA,Holemans JA,Kavanagh T,Kerr KM,Ledson M,Lifford KJ,McRonald FE,Nair A,Page RD,Parmar MKB,Rassl DM,Rintoul RC,Screaton NJ,Wald NJ,Weller D,Williamson PR,Yadegarfar G,Hansell DM UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.. vol.71, (2) 161.
10.1136/thoraxjnl-2015-207140
Thorax 2016
Lee JW,Morris JK,Wald NJ Grapefruit Juice and Statins. vol.129, (1) 26.
10.1016/j.amjmed.2015.07.036
AMERICAN JOURNAL OF MEDICINE 2016
Wald NJ,Bestwick JP Performance of antenatal reflex DNA screening for Down's syndrome. vol.22, (4) 168.
10.1177/0969141315581005
JOURNAL OF MEDICAL SCREENING 2015
Wald NJ,Huttly WJ,Bestwick JP,Aquilina J,Peregrine E Reflex antenatal DNA screening for Down syndrome. vol.35, (11) 1154.
10.1002/pd.4658
PRENATAL DIAGNOSIS 2015
Morris JK,Wald NJ,Springett AL Occupational Exposure to Hydrazine and Subsequent Risk of Lung Cancer: 50-Year Follow-Up. vol.10, (9) paginationBegin.
10.1371/journal.pone.0138884
PLOS ONE 2015
White IR,Rapsomaniki E,Emerging Risk Factors Collaboration null Covariate-adjusted measures of discrimination for survival data.. vol.57, (4) 592.
10.1002/bimj.201400061
Biom J 2015
Bestwick JP,Wald NJ Antenatal screening for Down's syndrome, trisomy 18, and trisomy 13: Reporting a single screening result for all three. vol.22, (2) 100.
10.1177/0969141315575545
JOURNAL OF MEDICAL SCREENING 2015
Wald NJ,Morris JK Erratum to: Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example [Eur J Epidemiol, (2014), 29, (605-612) DOI 10.1007/s10654-014-9932-1]. vol.30, (6) 521.
10.1007/s10654-015-0035-4
European Journal of Epidemiology 2015
Wald NJ,Morris JK Erratum to: Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example.. vol.30, (6) 521.
10.1007/s10654-015-0035-4
Eur J Epidemiol 2015
Wald NJ,Bestwick JP Presentation of meta-analysis plots. vol.22, (1) 49.
10.1177/0969141314556490
JOURNAL OF MEDICAL SCREENING 2015
Bestwick JP,Huttly WJ,Wald NJ Untitled. vol.22, (1) 52.
10.1177/0969141315571499
JOURNAL OF MEDICAL SCREENING 2015
Wald DS,Bestwick JP,Reiman L,Brendell R,Wald NJ Randomised Trial of Text Messaging on Adherence to Cardiovascular Preventive Treatment (INTERACT Trial). vol.9, (12) paginationBegin.
10.1371/journal.pone.0114268
PLOS ONE 2014
Wald NJ,Morris JK Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example.. vol.29, (9) 605.
10.1007/s10654-014-9932-1
Eur J Epidemiol 2014
Huttly W,Bestwick J,Wald N Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome.. vol.34, (4) 406.
10.1002/pd.4313
Prenat Diagn 2014
Emerging Risk Factors Collaboration null,Di Angelantonio E,Gao P,Khan H,Butterworth AS,Wormser D,Kaptoge S,Kondapally Seshasai SR,Thompson A,Sarwar N,Willeit P,Ridker PM,Barr ELM,Khaw K-T,Psaty BM,Brenner H,Balkau B,Dekker JM,Lawlor DA,Daimon M,Willeit J,Njølstad I,Nissinen A,Brunner EJ,Kuller LH,Price JF,Sundström J,Knuiman MW,Feskens EJM,Verschuren WMM,Wald N,Bakker SJL,Whincup PH,Ford I,Goldbourt U,Gómez-de-la-Cámara A,Gallacher J,Simons LA,Rosengren A,Sutherland SE,Björkelund C,Blazer DG,Wassertheil-Smoller S,Onat A,Marín Ibañez A,Casiglia E,Jukema JW,Simpson LM,Giampaoli S,Nordestgaard BG,Selmer R,Wennberg P,Kauhanen J,Salonen JT,Dankner R,Barrett-Connor E,Kavousi M,Gudnason V,Evans D,Wallace RB,Cushman M,D'Agostino RB,Umans JG,Kiyohara Y,Nakagawa H,Sato S,Gillum RF,Folsom AR,van der Schouw YT,Moons KG,Griffin SJ,Sattar N,Wareham NJ,Selvin E,Thompson SG,Danesh J Glycated hemoglobin measurement and prediction of cardiovascular disease.. vol.311, (12) 1225.
10.1001/jama.2014.1873
JAMA 2014
Bestwick JP,John R,Maina A,Guaraldo V,Joomun M,Wald NJ,Lazarus JH Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs).. vol.430, (issue) 33.
10.1016/j.cca.2013.12.030
Clin Chim Acta 2014
Wald NJ,Bestwick JP Is the area under an ROC curve a valid measure of the performance of a screening or diagnostic test?. vol.21, (1) 51.
10.1177/0969141313517497
J Med Screen 2014
McRonald FE,Yadegarfar G,Baldwin DR,Devaraj A,Brain KE,Eisen T,Holemans JA,Ledson M,Screaton N,Rintoul RC,Hands CJ,Lifford K,Whynes D,Kerr KM,Page R,Parmar M,Wald N,Weller D,Williamson PR,Myles J,Hansell DM,Duffy SW,Field JK The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening.. vol.7, (3) 362.
10.1158/1940-6207.CAPR-13-0206
Cancer Prev Res (Phila) 2014
Wald N,Morris J Refining the American guidelines for prevention of cardiovascular disease. vol.383, (9917) 598.
10.1016/S0140-6736(14)60213-0
LANCET 2014
Wald DS,Morris JK,Wald NJ The authors reply. vol.370, (3) 283.
10.1056/NEJMc1314696
New England Journal of Medicine 2014
Wald DS,Morris JK,Wald NJ,PRAMI Investigators null Preventive angioplasty in myocardial infarction.. vol.370, (3) 283.
10.1056/NEJMc1314696
N Engl J Med 2014
Wald NJ,Law MR Cochrane report on lowering blood pressure. vol.21, (1) 3.
10.1177/0969141314525368
JOURNAL OF MEDICAL SCREENING 2014
Bestwick JP,Huttly WJ,Morris JK,Wald NJ Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women.. vol.9, (2) e89354.
10.1371/journal.pone.0089354
PLoS One 2014
Wald DS,Morris JK,Wald NJ Preventive Angioplasty in Myocardial Infarction. vol.370, (issue) 283.
10.1056/NEJMc1314696
N Engl J Med 2014
Wald NJ,Morris JK Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example.. vol.29, (9) 605.
10.1007/s10654-014-9932-1
European journal of epidemiology 2014
WALD NJ The Triple Test. vol.60, (1) 269.
10.1373/clinchem.2013.212050
Clinical Chemistry 2014
Wald NJ,Bestwick JP The area under the ROC curve: Is it a valid measure of screening performance?. vol.21, (4) 220.
10.1177/0969141314548908
JOURNAL OF MEDICAL SCREENING 2014
Bestwick JP,Huttly WJ,Wald NJ The estimation of median nuchal translucency values between 10 and 14 weeks of pregnancy. vol.21, (2) 110.
10.1177/0969141314536890
JOURNAL OF MEDICAL SCREENING 2014
Wald DS,Morris JK,Wald NJ,Chase AJ,Edwards RJ,Hughes LO,Berry C,Oldroyd KG,PRAMI Investigators null Randomized trial of preventive angioplasty in myocardial infarction.. vol.369, (12) 1115.
10.1056/NEJMoa1305520
N Engl J Med 2013
Wald NJ,Lambert-Messerlian G,Palomaki GE Dr Jacob (Jack) Canick – an appreciation. vol.33, (9) 813.
10.1002/pd.4186
Prenatal Diagnosis 2013
Bestwick JP,Huttly WJ,Wald NJ Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers.. vol.20, (2) 57.
10.1177/0969141313484904
J Med Screen 2013
Wald NJ The press, press releases, and raising unwarranted expectations.. vol.20, (2) 55.
10.1177/0969141313492150
J Med Screen 2013
Bestwick JP,Huttly WJ,Wald NJ Allowing for ethnic group in antenatal screening for Down's syndrome.. vol.20, (1) 52.
10.1177/0969141313486893
J Med Screen 2013
Wald NJ,Bestwick JP,Huttly WJ Improvements in antenatal screening for Down's syndrome.. vol.20, (1) 7.
10.1177/0969141313476496
J Med Screen 2013
Bestwick JP,Huttly WJ,Wald NJ Allowing for ethnic group in antenatal screening for Down's syndrome. vol.20, (1) 52.
10.1177/0969141313486893
JOURNAL OF MEDICAL SCREENING 2013
Wald NJ,Bestwick JP Incorporating DNA sequencing into current prenatal screening practice for Down's syndrome.. vol.8, (3) e58732.
10.1371/journal.pone.0058732
PLoS One 2013
Wald NJ,Haddow J Jacob (Jack) Canick (28 November 1944 -19 May 2013). vol.20, (2) 106.
10.1177/0969141313497356
Journal of Medical Screening 2013
Singh GM,Danaei G,Farzadfar F,Stevens GA,Woodward M,Wormser D,Kaptoge S,Whitlock G,Qiao Q,Lewington S,Di Angelantonio E,Vander Hoorn S,Lawes CMM,Ali MK,Mozaffarian D,Ezzati M,Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort null,Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) null,Emerging Risk Factor Collaboration (ERFC) null,Prospective Studies Collaboration (PSC) null The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.. vol.8, (7) e65174.
10.1371/journal.pone.0065174
PLoS One 2013
Simmonds MC,Wald NJ Risk estimation versus screening performance: a comparison of six risk algorithms for cardiovascular disease.. vol.19, (4) 201.
10.1258/jms.2012.012076
J Med Screen 2012
Wald NJ,Haddow JE The Canadian recommendations on screening for type 2 diabetes.. vol.19, (4) 163.
10.1177/0969141313476677
J Med Screen 2012
Wald N,Law M Statins for people at low risk of cardiovascular disease.. vol.380, (9856) 1818.
10.1016/S0140-6736(12)62028-5
Lancet 2012
Emerging Risk Factors Collaboration null Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.. vol.41, (5) 1419.
10.1093/ije/dys086
Int J Epidemiol 2012
Wald DS,Bestwick JP,Wald NJ Homocysteine as a cause of ischemic heart disease: the door remains open.. vol.58, (10) 1488.
10.1373/clinchem.2012.191791
Clin Chem 2012
Huttly WJ,Wald NJ The estimation of gestational age of pregnancy for use in screening for Down syndrome using ultrasound measurements and embryo transfer date.. vol.32, (10) 1008.
10.1002/pd.3931
Prenat Diagn 2012
Wald NJ,Bestwick JP,Huttly WJ Effect of interrupting prenatal Down syndrome screening due to a large nuchal translucency.. vol.32, (7) 655.
10.1002/pd.3881
Prenat Diagn 2012
Wald NJ,Morris JK Personalized medicine: hope or hype.. vol.33, (13) 1553.
10.1093/eurheartj/ehs089
Eur Heart J 2012
Bestwick JP,Huttly WJ,Wald NJ Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome. vol.32, (7) 713.
10.1002/pd.3925
Prenatal Diagnosis 2012
Lazarus JH,Bestwick JP,Channon S,Paradice R,Maina A,Rees R,Chiusano E,John R,Guaraldo V,George LM,Perona M,Dall'Amico D,Parkes AB,Joomun M,Wald NJ Antenatal Thyroid Screening and Childhood Cognitive Function. vol.67, (6) 337.
10.1097/OGX.0b013e31825bbd12
OBSTETRICAL & GYNECOLOGICAL SURVEY 2012
Wald NJ,Bestwick JP,Morris JK Body weight reduction to avoid the excess risk of type 2 diabetes.. vol.62, (599) e411.
10.3399/bjgp12X649098
Br J Gen Pract 2012
Wald NJ,Bestwick JP,George LM,Wu T,Morris JK Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers.. vol.19, (2) 60.
10.1258/jms.2012.011114
J Med Screen 2012
Lazarus JH,Bestwick JP,Wald NJ Antenatal Thyroid Screening and Childhood Cognitive Function REPLY. vol.366, (17) 1641.
10.1056/NEJMc1202720
NEW ENGLAND JOURNAL OF MEDICINE 2012
Lazarus JH,Bestwick JP,Wald NJ The authors reply. vol.366, (17) 1641.
10.1056/NEJMc1202276
New England Journal of Medicine 2012
Wald NJ,Bestwick JP,Borrell A Adding ductus venosus blood flow as a categorical variable to the Combined and Integrated tests in Down's syndrome screening.. vol.19, (1) 49.
10.1258/jms.2011.011084
J Med Screen 2012
Bestwick JP,George LM,Wu T,Morris JK,Wald NJ The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.. vol.19, (1) 51.
10.1258/jms.2012.011085
J Med Screen 2012
Bestwick JP,Huttly WJ,Wald NJ Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome.. vol.32, (3) 299.
10.1002/pd.2936
Prenat Diagn 2012
Wald DS,Simmonds MC,Morris JK,Rothwell PM,Wald NJ Cost-effectiveness of diagnosis of high blood pressure in primary care.. vol.379, (9817) 709.
10.1016/S0140-6736(12)60302-X
Lancet 2012
Lazarus JH,Bestwick JP,Channon S,Paradice R,Maina A,Rees R,Chiusano E,John R,Guaraldo V,George LM,Perona M,Dall'Amico D,Parkes AB,Joomun M,Wald NJ Antenatal thyroid screening and childhood cognitive function.. vol.366, (6) 493.
10.1056/NEJMoa1106104
N Engl J Med 2012
Rapsomaniki E,White IR,Wood AM,Thompson SG,Emerging Risk Factors Collaboration null A framework for quantifying net benefits of alternative prognostic models.. vol.31, (2) 114.
10.1002/sim.4362
Stat Med 2012
Wald NJ,Bestwick JP,George LM,Huttly WJ Antenatal screening for Down syndrome using serum placental growth factor with the combined, quadruple, serum integrated and integrated tests.. vol.7, (10) e46955.
10.1371/journal.pone.0046955
PLoS One 2012
Wald DS,Wald NJ Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach. vol.18, (3) 612.
10.1111/j.1365-2753.2011.01637.x
Journal of Evaluation in Clinical Practice 2012
Wald DS,Morris JK,Wald NJ Randomized Polypill crossover trial in people aged 50 and over.. vol.7, (7) e41297.
10.1371/journal.pone.0041297
PLoS One 2012
Lazarus JH,Bestwick JP,Wald NJ Reply. vol.1, (2) 134.
10.1159/000338666
European Thyroid Journal 2012
WALD NJ The causation of neural tube defects – a journey of discovery and the challenge of prevention. vol.5, (issue) 285.
10.7707/hmj.v5i3211
Hamdan Medical Journal 2012
Morris JK,Wald DS,Wald NJ The evaluation of cascade testing for familial hypercholesterolemia. vol.158 A, (1) 78.
10.1002/ajmg.a.34368
American Journal of Medical Genetics, Part A 2012
Morris JK,Wald DS,Wald NJ The evaluation of cascade testing for familial hypercholesterolemia.. vol.158A, (1) 78.
10.1002/ajmg.a.34368
Am J Med Genet A 2012
Huttly WJ,Wald NJ An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined test.. vol.31, (13) 1317.
10.1002/pd.2890
Prenat Diagn 2011
Wald DS,Kasturiratne A,Godoy A,Ma L,Bestwick JP,Brewer N,Wald NJ Child-parent screening for familial hypercholesterolemia.. vol.159, (5) 865.
10.1016/j.jpeds.2011.06.006
J Pediatr 2011
Wald NJ Commentary: a brief history of folic acid in the prevention of neural tube defects.. vol.40, (5) 1154.
10.1093/ije/dyr131
Int J Epidemiol 2011
Field JK,Duffy S,Baldwin D,Brain K,Eisen T,Hands CJD,Kerr KM,Page R,Parmar M,Wald N,Weller D,Whynes D,Williamson P,Hansell D UNITED KINGDOM LUNG CANCER SCREENING (UKLS) TRIAL. vol.6, (6) S1382.
doi
JOURNAL OF THORACIC ONCOLOGY 2011
Wald N Unified prenatal screening for Down's syndrome and pre-eclampsia (vol 44, pg 455, 2011). vol.44, (8-9) 749.
10.1016/j.clinbiochem.2011.05.001
CLINICAL BIOCHEMISTRY 2011
Wald NJ,Morris JK,Law MR Aspirin in the prevention of cancer.. vol.377, (9778) 1649.
10.1016/S0140-6736(11)60665-X
Lancet 2011
Wald NJ,Simmonds M,Morris JK Screening for future cardiovascular disease using age alone compared with multiple risk factors and age.. vol.6, (5) e18742.
10.1371/journal.pone.0018742
PLoS One 2011
Wald NJ AN UPDATE ON ANTENATAL SCREENING FOR DOWN'S SYNDROME. vol.49, (issue) S91.
doi
CLINICAL CHEMISTRY AND LABORATORY MEDICINE 2011
Wald N Unified prenatal screening for Down's syndrome and pre-eclampsia. vol.44, (7) 455.
10.1016/j.clinbiochem.2011.03.018
CLINICAL BIOCHEMISTRY 2011
Baldwin DR,Duffy SW,Wald NJ,Page R,Hansell DM,Field JK UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.. vol.66, (4) 308.
10.1136/thx.2010.152066
Thorax 2011
Wright C,Quake SR,Bianchi D,Wald NJ Community Corner: Opening the Pandora's box of prenatal genetic testing.. vol.17, (3) 250.
10.1038/nm0311-250
Nat Med 2011
Wald NJ,Morris JK Assessing Risk Factors as Potential Screening Tests A Simple Assessment Tool. vol.171, (4) 286.
10.1001/archinternmed.2010.378
ARCHIVES OF INTERNAL MEDICINE 2011
Wald NJ,Morris JK Assessing risk factors as potential screening tests: a simple assessment tool.. vol.171, (4) 286.
10.1001/archinternmed.2010.378
Arch Intern Med 2011
Wald DS,Morris JK,Wald NJ Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis.. vol.6, (2) e16473.
10.1371/journal.pone.0016473
PLoS One 2011
Simmonds M,Wald N SNPs and coronary heart disease.. vol.377, (9763) 379.
10.1016/S0140-6736(11)60123-2
Lancet 2011
Wald NJ,Oppenheimer P Discounting the value of life.. vol.18, (1) 1.
10.1258/jms.2010.010136
J Med Screen 2011
Wald NJ Genetic testing.. vol.18, (2) 55.
10.1258/jms.2011.011024
J Med Screen 2011
Simmonds MC,Wald N Screening for cardiovascular disease: concerns with a Norwegian proposal.. vol.18, (4) 165.
10.1258/jms.2011.011121
J Med Screen 2011
Wald NJ Some clarity in the management of DCIS in breast cancer screening.. vol.18, (3) 112.
10.1258/jms.2011.011079
J Med Screen 2011
MORRIS JK,Wald DS,Wald NJ The Evaluation of Cascade Testing for Familial Hypercholesterolaemia. vol.volume, (issue) paginationBegin.
10.1002/ajmg.a.34368
Am J Med Genet A. 2011
Wald DS,Wald NJ The Polypill in the prevention of cardiovascular disease.. vol.52, (1) 16.
10.1016/j.ypmed.2010.11.015
Prev Med 2011
Wald NJ Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.. vol.30, (7) 619.
10.1002/pd.2517
Prenat Diagn 2010
WALD NJ,Simmonds M Screening for future cardiovascular disease: the need for simplification. vol.340, (issue) c2442.
10.1136/bmj.c2442
BMJ: British Medical Journal 2010
Wald NJ,Wald DS The polypill concept.. vol.86, (1015) 257.
10.1136/hrt.2009.186429
Postgrad Med J 2010
Wald DS,Wald NJ The polypill in the primary prevention of cardiovascular disease.. vol.24, (1) 29.
10.1111/j.1472-8206.2009.00795.x
Fundam Clin Pharmacol 2010
Emerging Risk Factors Collaboration null,Kaptoge S,Di Angelantonio E,Lowe G,Pepys MB,Thompson SG,Collins R,Danesh J C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.. vol.375, (9709) 132.
10.1016/S0140-6736(09)61717-7
Lancet 2010
Abu-Helalah M,Law MR,Bestwick JP,Monson JP,Wald NJ A randomized double-blind crossover trial to investigate the efficacy of screening for adult hypothyroidism.. vol.17, (4) 164.
10.1258/jms.2010.010057
J Med Screen 2010
Sarwar N,Gao P,Kondapally Seshasai SR,Gobin R,Kaptoge S,Di Angelantonio E,Ingelsson E,Lawlor DA,Selvin E,Stampfer M,Stehouwer CDA,Lewington S,Pennells L,Thompson A,Sattar N,White IR,Ray KK,Danesh J,Tipping RW,Ford CE,Pressel SL,Folsom AR,Chambless LE,Wagenknecht LE,Panagiotakos DB,Pitsavos C,Chrysohoou C,Stefanadis C,Knuiman M,Whincup PH,Wannamethee SG,Morris RW,Kiechl S,Willeit J,Oberhollenzer F,Mayr A,Wald N,Ebrahim S,Yarnell JW,Gallacher J,Casiglia E,Tikhonoff V,Nietert PJ,Sutherland SE,Bachman DL,Keil JE,de Boer IH,Kizer JR,Mukamal KJ,Tybjærg-Hansen A,Nordestgaard BG,Benn M,Frikke-Schmidt R,Giampaoli S,Palmieri L,Panico S,Vanuzzo D,Pilotto L,Gómez de la Cámara A,Rubio MA,Simons L,McCallum J,Friedlander Y,Fowkes FGR,Lee AJ,Taylor J,Guralnik JM,Phillips CL,Wallace R,Blazer DG,Khaw KT,Brenner H,Raum E,Müller H,Rothenbacher D,Jansson JH,Wennberg P,Nissinen A,Donfrancesco C,Salomaa V,Harald K,Jousilahti P,Vartiainen E Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. vol.375, (9733) 2215.
10.1016/S0140-6736(10)60484-9
The Lancet 2010
Bestwick JP,Huttly WJ,Wald NJ Distribution of nuchal translucency in antenatal screening for Down's syndrome (vol 17, pg 8, 2010). vol.17, (2) 106.
10.1258/jms.2010.010351
JOURNAL OF MEDICAL SCREENING 2010
Bestwick JP,Huttly WJ,Wald NJ Distribution of nuchal translucency in antenatal screening for Down's syndrome.. vol.17, (1) 8.
10.1258/jms.2010.009107
J Med Screen 2010
Bestwick JP,Huttly WJ,Wald NJ Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndrome.. vol.17, (1) 13.
10.1258/jms.2010.009108
J Med Screen 2010
Wald N,Law M Medical screening. vol.volume, (issue) paginationBegin.
10.1093/med/9780199204854.003.030302
journal 2010
Wald NJ,Wald DS The polypill concept.. vol.96, (1) 1.
10.1136/hrt.2009.186429
Heart 2010
Wald N,Law M The Indian Polycap Study (TIPS).. vol.374, (9692) 781.
10.1016/S0140-6736(09)61584-1
Lancet 2009
WALD NJ,Law MR,Duffy SW Lives saved by breast cancer screening. vol.339, (issue) b3359.
10.1136/bmj.b3359
BMJ: British Medical Journal 2009
Gosden C,Tabor A,Leck I,Grant A,Alfirevic Z,Wald N Amniocentesis and chorionic villus sampling. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0019
journal 2009
Wald N,Leck I Antenatal and neonatal screening. vol.volume, (issue) 1.
10.1093/acprof:oso/9780192628268.001.0001
journal 2009
Wald N Down's syndrome. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0004
journal 2009
Wald N,Leck I,Muir Gray JA Ethics of antenatal and neonatal screening. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0022
journal 2009
Wald N Neural tube defects. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0003
journal 2009
Wald N Preface to the first edition. vol.volume, (issue) paginationBegin.
doi
journal 2009
Wald N,Leck I Preface to the second edition. vol.volume, (issue) paginationBegin.
doi
journal 2009
Wald N,Hackshaw A Tests using multiple markers. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0002
journal 2009
Cuckle HS,Wald N Tests using single markers. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0001
journal 2009
Wald N,Kennard A,Donnenfeld A,Leck I Ultrasound scanning for congenital abnormalities. vol.volume, (issue) paginationBegin.
10.1093/acprof:oso/9780192628268.003.0018
journal 2009
Emerging Risk Factors Collaboration null,Erqou S,Kaptoge S,Perry PL,Di Angelantonio E,Thompson A,White IR,Marcovina SM,Collins R,Thompson SG,Danesh J Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.. vol.302, (4) 412.
10.1001/jama.2009.1063
JAMA 2009
Wald NJ,Law MR,Duffy SW Breast screening saves lives.. vol.339, (issue) b2922.
10.1136/bmj.b2922
BMJ 2009
Wald NJ,Law MR,Duffy SW Breast screening: Breast screening saves lives. vol.339, (issue) paginationBegin.
10.1136/bmj.b2922
BMJ: British Medical Journal 2009
WALD NJ,Law MR,Duffy SW Reduction in breast cancer mortality from mammographic screening. vol.338, (issue) b2561.
10.1136/bmj.b2561
BMJ: British Medical Journal 2009
Law M,Morris JK,Wald N Drug prevention of hypertension Authors' reply. vol.339, (issue) paginationBegin.
10.1136/bmj.b2602
BRIT MED J 2009
Wald N TAKING THE POLYPILL CONCEPT FORWARD. vol.10, (2) paginationBegin.
doi
ATHEROSCLEROSIS SUPP 2009
Wald N THE NEED TO SIMPLIFY CLINICAL GUIDELINES. vol.10, (2) paginationBegin.
doi
ATHEROSCLEROSIS SUPPLEMENTS 2009
Law MR,Morris JK,Wald NJ Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. vol.338, (7705) 1245.
10.1136/bmj.b1665
BMJ (Online) 2009
Law MR,Morris JK,Wald NJ Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.. vol.338, (issue) b1665.
10.1136/bmj.b1665
BMJ 2009
Bestwick JP,Wald NJ,Rudnicka AR Cost of Integrated, sequential and contingent prenatal screening for Down’s syndrome. vol.338, (issue) b138.
10.1136/bmj.b138
BMJ: British Medical Journal 2009
Whitlock G,Lewington S,Sherliker P,Clarke R,Emberson J,Halsey J,Qizilbash N,Collins R,Peto R,Lewington S,MacMahon S,Peto R,Aromaa A,Baigent C,Carstensen J,Chen Z,Clarke R,Collins R,Duffy S,Kromhout D,Neaton J,Qizilbash N,Rodgers A,Tominaga S,Tornberg S,Tunstall-Pedoe H,Whitlock G,Chambless L,De Backer G,De Bacquer D,Kornitzer M,Whincup P,Wannamethee SG,Morris R,Wald N,Morris J,Law M,Knuiman M,Bartholomew H,Smith GD,Sweetnam P,Elwood P,Yarnell J,Kronmal R,Kromhout D,Sutherland S,Keil J,Jensen G,Schnohr P,Hames C,Tyroler A,Aromaa A,Knekt P,Reunanen A,Tuomilehto J,Jousilahti P,VArtiainen E,Puska P,Kuznetsova T,Richart T,Staessen J,Thijs L,Jorgensen T,Thomsen T,Sharp D,Curb JD,Qizilbash N,Iso H,Sato S,Kitamura A,Naito Y,Benetos A,Guize L,Goldbourt U,Tomita M,Nishimoto Y,Murayama T,Criqui M,Davis C,Hart C,Smith GD,Hole D,Gillis C,Jacobs D,Blackburn H,Luepker R,Neaton J,Eberly L,Cox C,Levy D,D'Agostino R,Silbershatz H,Tverdal A,Selmer R,Meade T,Garrow K,Cooper J,Speizer F,Stampfer M,Menotti A,Spagnolo A,Tsuji I,Imai Y,Ohkubo T,Hisamichi S,Haheim L,Holme I,Hjermann I,Leren P,Ducimetiere P,Empana J,Jamrozik K,Broadhurst R,Assmann G,Schulte H,Bengtsson C,Bjorkelund C,Lissner L,Sorlie P,Garcia-Palmieri M,Barrett-Conner E,Criqui M,Langer R,Hart C,Smith GD,Hole D,Nakachi K,Imai K,Fang X,Li S,Buzina R,Nissinen A,Aravanis C,Dontas A,Kafatos A,Menotti A,Adachi H,Toshima H,Imaizumi T,Kromhout D,Nedeljkovic S,Ostojic M,Chen Z,Tunstall-Pedoe H,Nakayama T,Yoshiike N,Yokoyama T,Date C,Tanaka H,Keller J,Bonaa K,Arnesen E,Tunstall-Pedoe H,Rimm E,Gaziano M,Buring JE,Hennekens C,Tornberg S,Carstensen J,Shipley M,Leon D,Marmot M,Clarke R,Collins R,Emberson J,Halsey J,Lewington S,Palmer A,Parish S,Peto R,Sherliker P,Whitlock G,PSC Collaborator ARIC null Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. vol.373, (9669) 1083.
10.1016/S0140-6736(09)60318-4
LANCET 2009
Wald DS,Law M,Morris JK,Bestwick JP,Wald NJ Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.. vol.122, (3) 290.
10.1016/j.amjmed.2008.09.038
Am J Med 2009
WALD NJ,Law MR Breast screening: the facts — or maybe not. vol.338, (issue) b86.
10.1136/bmj.b86
BMJ: British Medical Journal 2009
Wald NJ,Huttly WJ,Murphy KW,Ali K,Bestwick JP,Rodeck CH Antenatal screening for Down's syndrome using the Integrated test at two London hospitals.. vol.16, (1) 7.
10.1258/jms.2009.008094
J Med Screen 2009
Borrell A,Borobio V,Bestwick JP,Wald NJ Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.. vol.16, (3) 112.
10.1258/jms.2009.009043
J Med Screen 2009
Wald NJ,Morris JK,Walker K,Simpson JM Prenatal screening for serious congenital heart defects using nuchal translucency: a meta-analysis.. vol.28, (12) 1094.
10.1002/pd.2124
Prenat Diagn 2008
Wald DS,Law M,Mills S,Bestwick JP,Morris JK,Wald NJ A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.. vol.30, (11) 2030.
10.1016/j.clinthera.2008.11.003
Clin Ther 2008
Wald NJ,Bestwick JP,Canick JA Contingent screening for Down syndrome.. vol.28, (8) 781.
10.1002/pd.2032
Prenat Diagn 2008
Bayston R,Russell A,Wald NJ,Hoffbrand AV Folic acid fortification and cancer risk - Authors' reply. vol.371, (9621) 1335.
10.1016/S0140-6736(08)60591-7
Lancet 2008
Law M,Wald N Cholesterol, statins, and mortality.. vol.371, (9619) 1161.
10.1016/S0140-6736(08)60516-4
Lancet 2008
Wald NJ,Huttly WJ,Bestwick JP Inhibin-A concentrations between 14 and 22 weeks of gestation.. vol.28, (4) 360.
10.1002/pd.1964
Prenat Diagn 2008
Wald NJ,Morris JK,Young NJ,Wald DS Meta-analysis audit trail. vol.371, (9612) 558.
10.1016/S0140-6736(08)60266-4
LANCET 2008
Bestwick JP,Huttly WJ,Wald NJ First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.. vol.15, (4) 204.
10.1258/jms.2008.008049
J Med Screen 2008
Wald NJ Guidance on terminology. vol.15, (1) 50.
10.1258/jms.2008.008got
Journal of Medical Screening 2008
Morris JK,Bestwick J,Wald NJ Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.. vol.15, (2) 55.
10.1258/jms.2008.007105
J Med Screen 2008
Bayston R,Russell A,Wald NJ,Hoffbrand AV Folic acid fortification and cancer risk.. vol.370, (9604) 2004.
10.1016/S0140-6736(07)61861-3
Lancet 2007
Prospective Studies Collaboration null,Lewington S,Whitlock G,Clarke R,Sherliker P,Emberson J,Halsey J,Qizilbash N,Peto R,Collins R Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.. vol.370, (9602) 1829.
10.1016/S0140-6736(07)61778-4
Lancet 2007
Wald DS,Bestwick JP,Wald NJ Familial hypercholesterolaemia: screening needs a fresh approach.. vol.335, (7628) 1007.
10.1136/bmj.39395.370278.80
BMJ 2007
Wald DS,Bestwick JP,Wald NJ Screening needs a fresh approach. vol.335, (7628) 1007.
10.1136/bmj.39395.370278.80
BMJ 2007
Wald NJ,Oakley GP Erratum: Should folic acid fortification be mandatory? Yes (British Medical Journal (2007) 334, (1252)). vol.335, (7623) 754.
doi
British Medical Journal 2007
Wald NJ,Oakley GP Should folic acid fortification be mandatory? Yes (vol 334, pg 1252, 2007). vol.335, (7623) 754.
doi
BRIT MED J 2007
Wald DS,Bestwick JP,Wald NJ Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. vol.335, (7620) 599.
10.1136/bmj.39300.616076.55
BMJ 2007
Wald NJ,Oakley GP Should folic acid fortification be mandatory? Yes.. vol.334, (7606) 1252.
10.1136/bmj.39232.493252.47
BMJ 2007
Wald NJ,Bestwick JP,Barnes IM,Kellner LH Anomalous marker patterns in Down syndrome screening.. vol.27, (2) 185.
10.1002/pd.1633
Prenat Diagn 2007
Law MR,Morris JK,Wald NJ Calcium channel blockers and headache.. vol.63, (2) 157.
10.1111/j.1365-2125.2006.02751.x
Br J Clin Pharmacol 2007
Wald N Neonatal screening: old dogma or sound principle?. vol.119, (2) 406.
10.1542/peds.2006-2158
Pediatrics 2007
Wald NJ,Bestwick JP,Morris JK Truncation limits for CT marker ratios in prenatal screening for Down syndrome.. vol.27, (2) 187.
10.1002/pd.1635
Prenat Diagn 2007
Morris JK,Wald NJ Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.. vol.14, (1) 5.
10.1258/096914107780154549
J Med Screen 2007
Barnes I,Lazarus J,Parkes A,Wald N,John R,Moina A,Perona M First trimester reference ranges for thyroid hormones: Similarities and differences between Wales and Turin, Italy. vol.68, (issue) 75.
doi
HORM RES 2007
Wald NJ Paying for publication. vol.14, (1) 1.
10.1258/096914107780154512
J MED SCREEN 2007
Morris JK,Wald NJ Prevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004.. vol.14, (2) 55.
10.1258/096914107781261945
J Med Screen 2007
Wald NJ Screening: a step too far. A matter of concern.. vol.14, (4) 163.
10.1258/096914107782912040
J Med Screen 2007
Emerging Risk Factors Collaboration null,Danesh J,Erqou S,Walker M,Thompson SG,Tipping R,Ford C,Pressel S,Walldius G,Jungner I,Folsom AR,Chambless LE,Knuiman M,Whincup PH,Wannamethee SG,Morris RW,Willeit J,Kiechl S,Santer P,Mayr A,Wald N,Ebrahim S,Lawlor DA,Yarnell JWG,Gallacher J,Casiglia E,Tikhonoff V,Nietert PJ,Sutherland SE,Bachman DL,Keil JE,Cushman M,Psaty BM,Tracy RP,Tybjaerg-Hansen A,Nordestgaard BG,Frikke-Schmidt R,Giampaoli S,Palmieri L,Panico S,Vanuzzo D,Pilotto L,Simons L,McCallum J,Friedlander Y,Fowkes FGR,Lee AJ,Smith FB,Taylor J,Guralnik J,Phillips C,Wallace R,Blazer D,Khaw KT,Jansson JH,Donfrancesco C,Salomaa V,Harald K,Jousilahti P,Vartiainen E,Woodward M,D'Agostino RB,Wolf PA,Vasan RS,Pencina MJ,Bladbjerg EM,Jorgensen T,Moller L,Jespersen J,Dankner R,Chetrit A,Lubin F,Rosengren A,Wilhelmsen L,Lappas G,Eriksson H,Bjorkelund C,Cremer P,Nagel D,Tilvis R,Strandberg T,Rodriguez B,Bouter LM,Heine RJ,Dekker JM,Nijpels G,Stehouwer CDA,Rimm E,Pai J,Sato S,Iso H,Kitamura A,Noda H,Goldbourt U,Salomaa V,Salonen JT,Nyyssönen K,Tuomainen T-P,Deeg D,Poppelaars JL,Meade T,Cooper J,Hedblad B,Berglund G,Engstrom G,Döring A,Koenig W,Meisinger C,Mraz W,Kuller L,Selmer R,Tverdal A,Nystad W,Gillum R,Mussolino M,Hankinson S,Manson J,De Stavola B,Knottenbelt C,Cooper JA,Bauer KA,Rosenberg RD,Sato S,Naito Y,Holme I,Nakagawa H,Miura H,Ducimetiere P,Jouven X,Crespo C,Garcia-Palmieri M,Amouyel P,Arveiler D,Evans A,Ferrieres J,Schulte H,Assmann G,Shepherd J,Packard C,Sattar N,Cantin B,Lamarche B,Després J-P,Dagenais GR,Barrett-Connor E,Wingard D,Bettencourt R,Gudnason V,Aspelund T,Sigurdsson G,Thorsson B,Trevisan M,Witteman J,Kardys I,Breteler M,Hofman A,Tunstall-Pedoe H,Tavendale R,Lowe GDO,Ben-Shlomo Y,Howard BV,Zhang Y,Best L,Umans J,Onat A,Meade TW,Njolstad I,Mathiesen E,Lochen ML,Wilsgaard T,Gaziano JM,Stampfer M,Ridker P,Ulmer H,Diem G,Concin H,Rodeghiero F,Tosetto A,Brunner E,Shipley M,Buring J,Cobbe SM,Ford I,Robertson M,He Y,Ibanez AM,Feskens EJM,Kromhout D,Collins R,Di Angelantonio E,Kaptoge S,Lewington S,Orfei L,Pennells L,Perry P,Ray K,Sarwar N,Scherman M,Thompson A,Watson S,Wensley F,White IR,Wood AM The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.. vol.22, (12) 839.
10.1007/s10654-007-9165-7
Eur J Epidemiol 2007
Morris JK,Wald NJ The effect of correlations between screening markers on screening performance.. vol.14, (3) 151.
10.1258/096914107782066149
J Med Screen 2007
Wald N The POLYPILL (R) concept and potential. vol.24, (issue) 21.
doi
JOURNAL OF HYPERTENSION 2006
Huttly WJ,Morris JK,Bestwick JP,Wald NJ,Murphy K,Pandya PP Three stage contingent screening for Down syndrome.. vol.26, (12) 1183.
10.1002/pd.1579
Prenat Diagn 2006
Wald DS,Wald NJ,Morris JK,Law M Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.. vol.333, (7578) 1114.
10.1136/bmj.39000.486701.68
BMJ 2006
Wald NJ,Bestwick JP,Morris JK Cross trimester marker ratios: parameter estimates valid with no inconsistency. vol.26, (10) 994.
10.1002/pd.1566
PRENATAL DIAG 2006
Wald NJ Obesity and public health law.. vol.355, (12) 1283.
10.1056/NEJMc061878
N Engl J Med 2006
Wald NJ To the editor [11]. vol.355, (12) 1283.
doi
New England Journal of Medicine 2006
Wald NJ,Law MR A strategy to reduce cardiovascular disease by more than 80% (vol 326, pg 1419, 2003). vol.60, (9) 823.
10.1136/jech.2005/040253corr2
J EPIDEMIOL COMMUN H 2006
Morris JK,George LM,Wu T,Wald NJ Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies.. vol.95, (1) 112.
10.1038/sj.bjc.6603200
Br J Cancer 2006
Wald NJ,Bestwick JP,Morris JK Cross-trimester marker ratios in prenatal screening for Down syndrome.. vol.26, (6) 514.
10.1002/pd.1446
Prenat Diagn 2006
Wald NJ,Barnes IM,Birger R,Huttly W Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy (vol 26, pg 539, 2006). vol.26, (6) 589.
10.1002/pd.1492
PRENATAL DIAG 2006
Wald NJ,Barnes IM,Birger R,Huttly W Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.. vol.26, (6) 539.
10.1002/pd.1455
Prenat Diagn 2006
Law M,Wald NJ Efficacy and safety of cholesterol-lowering treatment.. vol.367, (9509) 469.
10.1016/S0140-6736(06)68170-1
Lancet 2006
WALD NJ,Rudnicka AR Antenatal screening for Down syndrome using the Integrated test. vol.volume, (issue) 79.
doi
journal 2006
Wald NJ,Rodeck C,Hackshaw AK,Walters J,Chitty L,Mackinson AM,Bestwick JP First- and second-trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) (vol 10, pg 56, 2003). vol.13, (1) 51.
10.1258/096914106776179872
J MED SCREEN 2006
Wald NJ Guidance on terminology.. vol.13, (1) 53.
10.1258/096914106776179818
J Med Screen 2006
WALD NJ Information leaflets in medical screening. vol.13, (3) 109.
10.1258/096914106778440653
Journal of Medical Screening 2006
WALD NJ,Morris JK,Ibison J,Wu T,George LM Screening in early pregnancy for pre-eclampsia using Down syndrome Quadruple test markers. vol.26, (6) 559.
10.1002/pd.1459
Prenatal Diagnosis 2006
WALD NJ,Rudnicka AR,Bestwick JP Sequential and contingent prenatal screening for Down syndrome. vol.26, (9) 769.
10.1002/pd.1498
Prenatal Diagnosis 2006
Wald NJ,Bestwick JP,Huttly WJ,Morris JK,George LM Validation plots in antenatal screening for Down's syndrome.. vol.13, (4) 166.
10.1177/096914130601300402
J Med Screen 2006
Malone FD,Canick JA,Ball RH,Nyberg DA,Comstock CH,Bukowski R,Berkowitz RL,Gross SJ,Dugoff L,Craigo SD,Timor-Tritsch IE,Carr SR,Wolfe HM,Dukes K,Bianchi DW,Rudnicka AR,Hackshaw AK,Lambert-Messerlian G,Wald NJ,D'Alton ME,First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium null First-trimester or second-trimester screening, or both, for Down's syndrome.. vol.353, (19) 2001.
10.1056/NEJMoa043693
N Engl J Med 2005
Law M,Morris JK,Jordan R,Wald N Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants.. vol.112, (15) 2301.
10.1161/CIRCULATIONAHA.104.529628
Circulation 2005
Clarke R,Frost C,Sherliker P,Lewington S,Collins R,Brattstrom L,Brouwer I,van Dusseldorp M,Steegers-Theunissen RPM,Cuskelly G,Ward M,McNulty H,Scott J,den Heijer M,Blom H,van der Put N,Shorah CJ,Malinow MR,McMahon M,Tobert J,Kush D,Joosten E,Riezier R,Pietrzik K,Dierkes J,Bronstrup A,Jacques P,Mason J,Rosenberg I,Thambyrajah J,Landray M,Townend J,Wheeler D,Ubbink J,van Oort F,Melse-Boonstra A,Verhoef P,Woodside JV,Yarnell J,Young IS,Evans AE,Wald D,Law M,Wald N,Homocysteine Lowering Trialists' C null Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. vol.82, (4) 806.
10.1093/ajcn/82.4.806
AM J CLIN NUTR 2005
Wald NJ,Rish S Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.. vol.25, (9) 740.
10.1002/pd.1258
Prenat Diagn 2005
Wald NJ,Rodeck C,Hackshaw AK,Rudnicka A SURUSS in perspective.. vol.29, (4) 225.
10.1053/j.semperi.2005.05.006
Semin Perinatol 2005
Wald NJ Which gestational age estimate to use in AFP screening for spina bifida?. vol.25, (7) 623.
10.1002/pd.1225
Prenat Diagn 2005
Law M,Morris JK,Wald N,Luczynska C,Burney P Changes in atopy over a quarter of a century, based on cross sectional data at three time periods.. vol.330, (7501) 1187.
10.1136/bmj.38435.582975.AE
BMJ 2005
Huang T,Alberman E,Wald N,Summers AM Triploidy identified through second-trimester serum screening.. vol.25, (3) 229.
10.1002/pd.1115
Prenat Diagn 2005
Strong K,Wald N,Miller A,Alwan A,WHO Consultation Group null Current concepts in screening for noncommunicable disease: World Health Organization Consultation Group Report on methodology of noncommunicable disease screening.. vol.12, (1) 12.
10.1258/0969141053279086
J Med Screen 2005
Morris JK,Wald NJ Graphical presentation of distributions of risk in screening.. vol.12, (3) 155.
10.1258/0969141054855283
J Med Screen 2005
Law M,Wald N,Morris J Lowering blood pressure to prevent myocardial infarction and stroke: A new preventive strategy. vol.21, (1) 145.
10.1017/S0266462305220196
INT J TECHNOL ASSESS 2005
Wald NJ Medical screening society working groups.. vol.12, (2) 59.
10.1258/0969141053908311
J Med Screen 2005
Rudnicka AR,WALD NJ,Hackshaw AK,Bianchi DW,Dukes K,Carr SR,Craigo SD,Gross SJ,Lambert-Messerlain G,Malone FD,Canick JA,Ball RH,Comstock CH,Bukowski R,D'Alton ME,Dugoff L,Timor-Tritisch IE,Wofe HM Results of the NICHD Multicenter Down Syndrome Screening Study. vol.volume, (issue) paginationBegin.
doi
New England Journal of Medicine 2005
WALD NJ,Law MR Screening for future coronary heart disease. vol.volume, (issue) 706.
10.1093/acprof:oso/9780198525738.003.0042
journal 2005
Wald DS,Law MR,Wald NJ,Morris JK Serum homocysteine and coronary heart disease. vol.volume, (issue) 239.
doi
journal 2005
Wald NJ,Morris JK,Rish S The efficacy of combining several risk factors as a screening test.. vol.12, (4) 197.
10.1258/096914105775220642
J Med Screen 2005
Wald NJ,Rodeck C,Hackshaw AK,Rudnicka A The future of antenatal screening for Down's Syndrome - Reply. vol.112, (1) paginationBegin.
10.1111/j.1471-0528.2005.00475.x
BJOG-INT J OBSTET GY 2005
Alfirevic Z The future of antenatal screening for Down's Syndrome.. vol.112, (1) 128.
10.1111/j.1471-0528.2005.00509.x
BJOG 2005
Morris JK,Alberman E,Wald NJ Recurrent false-positives in AFP screening for open neural tube defects- Reply to Professor Hook. vol.24, (12) 1018.
10.1002/pd.1045
PRENATAL DIAG 2004
Wald NJ,Huttly WJ,Rudnicka AR Recurrent false-positives in AFP screening for open neural tube defects.. vol.24, (12) 1018.
10.1002/pd.986
Prenat Diagn 2004
Wald NJ,Law M,Hoffbrand AV Folic acid fortification in the prevention of neural tube defects.. vol.80, (6) 1665.
10.1093/ajcn/80.6.1665
Am J Clin Nutr 2004
Wald N,Rodeck C,Hackshaw A,Rudnicka A Correlations between nuchal translucency and serum markers in SURUSS.. vol.24, (10) 835.
10.1002/pd.966
Prenat Diagn 2004
Wald NJ,Rodeck CR,Ruldnicka AR,Hackshaw AK Nuchal translucency and gestational age - Response to Nicolaides. vol.24, (10) 834.
10.1002/pd.1046
PRENATAL DIAG 2004
Huttly W,Rudnicka A,Wald NJ Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.. vol.24, (10) 804.
10.1002/pd.994
Prenat Diagn 2004
Morris JK,Law MR,Wald NJ Is cascade testing a sensible method of screening a population for autosomal recessive disorders?. vol.128A, (3) 271.
10.1002/ajmg.a.30024
Am J Med Genet A 2004
Wald N,Willett W Reversing the obesity epidemic.. vol.364, (9429) 140.
10.1016/S0140-6736(04)16624-5
Lancet 2004
Wald NJ Commentary: silent prevention. vol.329, (7456) 43.
10.1136/bmj.329.7456.43
BRIT MED J 2004
Wald NJ,Rodeck C,Hackshaw AK,Rudnicka A SURUSS in perspective.. vol.111, (6) 521.
10.1111/j.1471-0528.2004.00193.x
BJOG 2004
Honein MA,Beresford S,Wald N,Erickson JD,Rasmussen SA The future of folic acid - Beyond a role in the prevention of neural tube defects.. vol.159, (11) S71.
doi
AMERICAN JOURNAL OF EPIDEMIOLOGY 2004
Wald NJ Folic acid and the prevention of neural-tube defects - Reply. vol.350, (21) 2210.
doi
NEW ENGL J MED 2004
Wald NJ,Huttly WJ,Rudnicka AR Prenatal screening for Down syndrome: the problem of recurrent false-positives.. vol.24, (5) 389.
10.1002/pd.890
Prenat Diagn 2004
Greene N,Platt LD In response to 'Certificate of competence in performing specific procedures or tests in screening practice'.. vol.24, (4) 315.
10.1002/pd.812
Prenat Diagn 2004
Wald NJ,Rodeck CR,Rudnicka A,Hackshaw A In response to Nicolaides. vol.24, (4) 319.
10.1002/pd.856
PRENATAL DIAG 2004
Wald NJ First-trimester screening for Down's syndrome.. vol.350, (6) 619.
10.1056/NEJM200402053500621
N Engl J Med 2004
Wald N,Rodeck C,Rudnicka A,Hackshaw A Nuchal translucency and gestational age.. vol.24, (2) 150.
10.1002/pd.840
Prenat Diagn 2004
Wald NJ,Law M,Hoffbrand VA Vitamin B-12 and folate deficiency in elderly persons.. vol.79, (2) 338.
10.1093/ajcn/79.2.338
Am J Clin Nutr 2004
Wald NJ,Bower C Folic acid and the prevention of neural-tube defects.. vol.350, (2) 101.
10.1056/NEJMp038186
N Engl J Med 2004
Wald NJ First-trimester screening for Down's syndrome.. vol.350, (6) paginationBegin.
doi
The New England journal of medicine 2004
WALD NJ In response to Nicolaides.. vol.24, (4) 317.
10.1002/pd.854
Prenatal Diagnosis. 2004
Law MR,Wald NJ,Morris K,Jordan RE,Weber MA,Morgan TO Low dose combination treatment increases efficacy of blood pressure lowering drugs and reduces adverse effects. vol.8, (1) 45.
10.1016/j.ehbc.2003.12.007
Evidence-Based Healthcare 2004
Law M,Wald NJ,Rudnicka AR,Rosenson RS Lowering LDL cholesterol reduces risk of ischaemic heart disease events. vol.8, (1) 48.
10.1016/j.ehbc.2003.12.008
Evidence-Based Healthcare 2004
RUDNICKA AR,Wald NJ,Huttly WJ Parental screening for Downs syndrome: the problem of recurrent false-positives.. vol.24, (issue) 389.
10.1002/pd.890
Prenatal Diagnosis. 2004
Wald NJ,Morris JK Reply: Prenatal screen for Fragile X syndrome. vol.24, (1) 68.
10.1002/pd.767
PRENATAL DIAG 2004
Law MR,Wald NJ,Morris JK,Jordan RE,Linden W Review: Lower dose combination antihypertensive therapy is preferable to standard dose single drug therapy. vol.9, (1) 11.
10.1136/ebm.9.1.11
Evidence-Based Medicine 2004
Law MR,Wald NJ,Morris JK The performance of blood pressure and other cardiovascular risk factors as screening tests for ischaemic heart disease and stroke.. vol.11, (1) 3.
10.1177/096914130301100102
J Med Screen 2004
Rudnicka AR,Wald NJ Choice between using delta-NT or NT MoM.. vol.22, (6) 659.
10.1002/uog.936
Ultrasound Obstet Gynecol 2003
Malone FD,Wald NI,Canick JA,Ball RH,Nyberg DA,Comstock CH,Bukowski R,Berkowitz RL,Gross SJ,Dugoff L,Craigo SD,Timor IE,Carr SR,Wolfe HM,Dukes KA,Bianchi DW,Rudnicka A,Hackshaw A,Lambert-Messerlian G,D'Alton ME First- and second-trimester evaluation of risk (faster) trial: Principal results of the NICHD multicenter down syndrome screening study. vol.189, (6) S56.
10.1016/j.ajog.2003.10.001
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2003
Canick JA,Wald NJ,Malone FD,Porter TF,Nyberg DA,Comstock CH,Saade G,Eddleman K,Klugman S,Dugoff L,Craigo SD,Timor IE,Carr SR,Wolfe HM,Sullivan L,Lambert-Messerlian G,Rudnicka A,Hackshaw A,D'Alton ME Gestational age-based performance of Down syndrome screening markers: Results from the faster trial. vol.189, (6) S116.
10.1016/j.ajog.2003.10.194
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2003
Law M,Wald N,Morris J Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.. vol.7, (31) 1.
doi
Health technology assessment (Winchester, England) 2003
Malone FD,Wald NJ,Canick JA,Ball RH,Nyberg DA,Comstock CH,Saade G,Berkowitz RL,Gross S,Dugoff L,Craigo SD,Timor I,Carr SR,Wolfe HM,Sullivan L,Rudnicka A,Hackshaw A,Lambert-Messer-Lian G,D'Alton ME Use of overall population, center-specific, and sonographer-specific nuchal translucency medians in down syndrome screening: Which is best? (Results from the faster trial). vol.189, (6) S232.
10.1016/j.ajog.2003.10.642
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 2003
Wald N,Law M,Morris J,Rudnicka A,Jordan R "Polypill" to fight cardiovascular disease - Summary of rapid responses - Authors' reply. vol.327, (7418) 809.
10.1136/bmj.327.7418.809-a
BRIT MED J 2003
Wald N Certification of competence in performing specific procedures or tests in screening practice.. vol.23, (10) 861.
10.1002/pd.687
Prenat Diagn 2003
Wald NJ,Law MR A strategy to reduce cardiovascular disease by more than 80% (vol 326, gp 1419, 2003). vol.327, (7415) 586.
10.1136/bmj.326.7404.1419
BRIT MED J 2003
Wald NJ,Morris JK Teleoanalysis: combining data from different types of study.. vol.327, (7415) 616.
10.1136/bmj.327.7415.616
BMJ 2003
Wald NJ,Rish S,Hackshaw AK Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies.. vol.23, (7) 588.
10.1002/pd.627
Prenat Diagn 2003
Law MR,Wald NJ Environmental tobacco smoke and ischemic heart disease.. vol.46, (1) 31.
10.1016/S0033-0620(03)00078-1
Prog Cardiovasc Dis 2003
Boyle P,Autier P,Bartelink H,Baselga J,Boffetta P,Burn J,Burns HJG,Christensen L,Denis L,Dicato M,Diehl V,Doll R,Franceschi S,Gillis CR,Gray N,Griciute L,Hackshaw A,Kasler M,Kogevinas M,Kvinnsland S,La Vecchia C,Levi F,McVie JG,Maisonneuve P,Martin-Moreno JM,Bishop JN,Oleari F,Perrin P,Quinn M,Richards M,Ringborg U,Scully C,Siracka E,Storm H,Tubiana M,Tursz T,Veronesi U,Wald N,Weber W,Zaridze DG,Zatonski W,zur Hausen H European Code Against Cancer and scientific justification: third version (2003).. vol.14, (7) 973.
10.1093/annonc/mdg305
Ann Oncol 2003
Wald NJ,Law MR A strategy to reduce cardiovascular disease by more than 80%.. vol.326, (7404) 1419.
10.1136/bmj.326.7404.1419
BMJ 2003
Law MR,Wald NJ,Rudnicka AR Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.. vol.326, (7404) 1423.
10.1136/bmj.326.7404.1423
BMJ 2003
Law MR,Wald NJ,Morris JK,Jordan RE Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.. vol.326, (7404) 1427.
10.1136/bmj.326.7404.1427
BMJ 2003
Wald NJ,Morris JK,Rodeck CH,Haddow JE,Palomaki GE Cystic fibrosis: selecting the prenatal screening strategy of choice.. vol.23, (6) 474.
10.1002/pd.618
Prenat Diagn 2003
Wald NJ,Rodeck C,Hackshaw AK,Walters J,Chitty L,Mackinson AM First and second trimester antenatal screening for Down's syndrome: The results of the serum, urine and ultrasound screening study (SURUSS). vol.7, (11) paginationBegin.
doi
Health Technology Assessment 2003
Wald DS,Law M,Morris J,Wald NJ Folate and risk of cardiovascular disease. Study results were misinterpreted.. vol.326, (7397) 1035.
10.1136/bmj.326.7397.1035/a
BMJ 2003
Huang T,Alberman E,Watt HC,Wald NJ Using Down syndrome serum screening results to predict low birthweight.. vol.23, (5) 420.
10.1002/pd.613
Prenat Diagn 2003
Wald NJ,Morris JK A new approach to antenatal screening for Fragile X syndrome.. vol.23, (4) 345.
10.1002/pd.586
Prenat Diagn 2003
Wald NJ,Huttly WJ,Hackshaw AK Antenatal screening for Down's syndrome with the quadruple test.. vol.361, (9360) 835.
10.1016/S0140-6736(03)12680-3
Lancet 2003
Morris JK,Wald NJ,Mutton DE,Alberman E Comparison of models of maternal age-specific risk for Down syndrome live births.. vol.23, (3) 252.
10.1002/pd.568
Prenat Diagn 2003
Macgregor GA,He FJ,Perry IJ,Law MR,Wald NJ,Hooper L,Bartlett C,Smith GD,Ebrahim S Long term effects of advice to reduce dietary salt. vol.326, (7382) 222.
10.1136/bmj.326.7382.222/a
BMJ 2003
Law MR,Wald NJ Long term effects of advice to reduce dietary salt. Salt needs to be reduced in manufacturing and processing food.. vol.326, (7382) 222.
10.1136/bmj.326.7382.222/a
BMJ 2003
Oakley G,Wald N,Omenn G Provide the citizens of New Zealand the miracle of folic acid fortification.. vol.116, (1168) U302.
doi
N Z Med J 2003
Law MR,Wald NJ,Rudnick AR,Wierzbicki AS Atorvastatin and rosuvastatin reduce LDL-C more than other statins. vol.7, (4) 181.
10.1016/j.ebcm.2003.09.002
Evidence-based Cardiovascular Medicine 2003
WALD NJ,Husband JE CT-based screening for lung cancer: phiosophy, study designs and current trials.. vol.volume, (issue) 3.
doi
journal 2003
Wald NJ,Rodeck C,Hackshaw AK,Walters J,Chitty L,Mackinson AM First and second trimester antenatal screening for Down's syndrome: The results of the serum, urine and ultrasound screening study (SURUSS). vol.7, (11) paginationBegin.
10.3310/hta7110
Health Technology Assessment 2003
Wald NJ,Rodeck C,Hackshaw AK,Walters J,Chitty L,Mackinson AM,SURUSS Research Group null First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).. vol.7, (11) 1.
doi
Health Technol Assess 2003
Law MR,Wald NJ Long term effects of advice to reduce dietary salt. Salt needs to be reduced in manufacturing and processing food.. vol.326, (7382) paginationBegin.
doi
BMJ (Clinical research ed.) 2003
Law M,Wald N,Morris J Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.. vol.7, (31) 1.
10.3310/hta7310
Health Technol Assess 2003
WALD NJ Under new management! Medical Screening Society buys Journal of Medical Screening.. vol.10, (1) 1.
10.1258/096914103321610716
J Med Screen 2003
Wald N,Law M,MRC/BHF Heart Protection Study null MRC/BHF Heart Protection Study.. vol.360, (9347) 1781.
10.1016/S0140-6736(02)09327-3
Lancet 2002
Law MR,Watt HC,Wald NJ The underlying risk of death after myocardial infarction in the absence of treatment.. vol.162, (21) 2405.
10.1001/archinte.162.21.2405.
Arch Intern Med 2002
Law M,Wald NJ Risk factor thresholds - Reply. vol.325, (7372) 1115.
10.1136/bmj.325.7372.1114
BRIT MED J 2002
Wald NJ,Huttly W,Hackshaw AK,Christiansen M,Larsen SO,Nørgaard-Pedersen B,Howe D,Wellesley D Antenatal screening policies for Down's syndrome [3] (multiple letters). vol.325, (7371) 1034.
doi
British Medical Journal 2002
Wald NJ,Huttly W,Hackshaw AK Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.. vol.325, (7371) 1034.
10.1136/bmj.325.7371.1034
BMJ 2002
Hackshaw A,Wald N Estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening.. vol.22, (11) 1051.
10.1002/pd.426
Prenat Diagn 2002
Wald D,Law M,Wald N The serum folate response to the US mandatory fortification of grain products with folic acid.. vol.162, (19) 2254.
10.1001/archinte.162.19.2254
Arch Intern Med 2002
Clarke R,Collins R,Lewington S,Donald A,Alfthan G,Tuomilehto J,Arnesen E,Bonaa K,Blacher J,Boers GHJ,Bostom A,Bots ML,Grobee DE,Brattstrom L,Breteler MMB,Hofman A,Chambers JC,Kooner JS,Coull BM,Evans RW,Kuller LH,Evers S,Folsom AR,Freyburger G,Parrot F,Genst J,Dalery K,Graham IM,Daly L,Hoogeveen EK,Kostense PJ,Stehouwer CDA,Hopknis PN,Jacques P,Selhub J,Luft FC,Jungers P,Lindgren A,Lolin YI,Loehrer F,Fowler B,Mansoor MA,Malinow MR,Ducimetiere P,Nygard O,Refsum H,Vollset SE,Ueland PM,Omenn GS,Beresford SAA,Roseman JM,Parving HH,Gall MA,Perry IJ,Ebraham SB,Shaper AG,Robinson K,Jacobsen DW,Schwartz SM,Siscovick DS,Stampfer MJ,Henekens CH,Feskens EJM,Kromhout D,Ubbink J,Elwood P,Pickering J,Verhoef P,von Eckardstein A,Schulte H,Assmann G,Wald N,Law MR,Whincup PH,Wilcken DEL,Sherliker P,Linksted P,Smith GD,Witteman JCM,Israelsson B,Sexton G,Wu LL,Joubran R,Norrving B,Hultberg B,Andersson A,Johansson BB,Bergmark C,Svardal AM,Evans AE,Pancharuniti N,Lewis CA,Holman R,Stratton I,Johnston C,Morris J,Homocysteine Studies Collaboration null Homocysteine and risk of ischemic heart disease and stroke - A meta-analysis. vol.288, (16) 2015.
10.1001/jama.288.16.2015.
JAMA-J AM MED ASSOC 2002
Rudnicka AR,Wald NJ,Huttly W,Hackshaw AK Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.. vol.22, (10) 893.
10.1002/pd.440
Prenat Diagn 2002
Hackshaw A,Wald NJ Reporting partial screening results: is it confusing and unsatisfactory? Reply. vol.22, (7) 633.
10.1002/pd.361
PRENATAL DIAG 2002
Law MR,Wald NJ Risk factor thresholds: their existence under scrutiny.. vol.324, (7353) 1570.
10.1136/bmj.324.7353.1570
BMJ 2002
Wald NJ,Law M,Haddow JE,Craig WY Apolipoprotiens and prediction of fatal myocardial infarction.. vol.359, (9320) 1864.
10.1016/S0140-6736(02)08694-4
Lancet 2002
Wald NJ,Hackshaw AK Folic acid supplementation and neural tube defects.. vol.109, (1) 79.
10.1002/ajmg.10292
Am J Med Genet 2002
Tabor A,Watt HC,Wald NJ Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding.. vol.99, (4) 663.
10.1016/S0029-7844(01)01771-9
Obstet Gynecol 2002
Wald N First-trimester nuchal translucency screening.. vol.21, (4) 481.
doi
J Ultrasound Med 2002
Wald N Erratum: Quantifying the effect of folic acid (The Lancet (2069)). vol.359, (9306) 630.
doi
Lancet 2002
Wald N Quantifying the effect of folic acid (vol 358, pg 2069, 2001). vol.359, (9306) 630.
doi
LANCET 2002
Wald N,Malone FD,Ball RH,Berkowitz RL,Bianchi DW,Carr SR,Comstock CH,Craigo SD,D'Alton ME,De la Cruz F,Dugoff L,Eddleman KA,Gross SJ,Hankins GD,Hobbins JC,Merkatz IR,Nyberg DA,Saade GR,Wolfe HM,Chasen ST,Skupski DW,Chervenak FA,McCullough LB First-trimester nuchal translucency screening (multiple letters). vol.21, (4) 481.
10.7863/jum.2002.21.4.481
Journal of Ultrasound in Medicine 2002
WALD NJ First-trimester nuchal translucency screening. [and discussion]. vol.21, (4) 481.
doi
J Ultrasound Med 2002
WALD NJ,Forey B,Lee P,Hamling J International Smoking Statistics, 2nd Ed.. vol.volume, (issue) paginationBegin.
doi
journal 2002
Wald N,Law M MRC/BHF Heart Protection Study.. vol.360, (9347) paginationBegin.
10.1016/S0140-6736(02)11687-4
Lancet 2002
Wald NJ,Canick JA Seeking other disorders within antenatal serum screening programmes for Down's syndrome.. vol.9, (4) 145.
10.1136/jms.9.4.145
J Med Screen 2002
WALD NJ Should we adopt folic acid fortification in Europe?. vol.16, (4) A403.
10.1016/S0890-6238(02)00036-9
Reprod Toxicol 2002
Wald N The Medical Screening Society. vol.9, (1) 1.
10.1136/jms.9.1.1
J MED SCREEN 2002
Wald NJ,Law MR,Morris JK,Wald DS Quantifying the effect of folic acid.. vol.358, (9298) 2069.
10.1016/S0140-6736(01)07104-5
Lancet 2001
Law M,Wald NJ Cholesterol and all-cause mortality in Honolulu.. vol.358, (9296) 1904.
10.1016/S0140-6736(01)06906-9
Lancet 2001
Wald NJ Folic acid and neural tube defects. vol.55, (issue) 22.
doi
Forum of Nutrition 2001
Hackshaw AK,Wald NJ,George LM Singleton versus duplicate assays in maternal serum screening - Reply. vol.21, (10) 895.
10.1002/pd.185
PRENATAL DIAG 2001
Benn PA Singleton versus duplicate assays in maternal serum screening.. vol.21, (10) 894.
10.1002/pd.159
Prenat Diagn 2001
Hackshaw AK,Wald NJ Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome.. vol.21, (9) 737.
10.1002/pd.132
Prenat Diagn 2001
Webb PM,Law M,Varghese C,Forman D,Yuan JM,Yu M,Ross R,Limberg PJ,Mark SD,Taylor PR,Dawsey SM,Qiao YL,Aromaa A,Knekt P,Kosunen TU,Heinonen OP,Virtamo J,Tulinius H,Watanabe Y,Ozasa K,Kurata JH,Hansen S,Melby KK,Aase S,Jellum E,Vollset SE,Siman JH,Forsgren A,Berglund G,Floren CH,Lin JT,Chen CJ,Forman D,Law M,Wald NJ,Parsonnet J,Friedman GD,Blaser MJ,Nomura A,Stemmermann GN,Helicobacter Canc Collaborative Gr null Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. vol.49, (3) 347.
10.1136/gut.49.3.347
GUT 2001
Hackshaw AK,Wald NJ Inaccurate estimation of risk in second trimester serum screening for Down syndrome among women who have already had first trimester screening.. vol.21, (9) 741.
10.1002/pd.131
Prenat Diagn 2001
Sasieni P,Cuzick J Routine audit is an ethical requirement of screening.. vol.322, (7295) 1179.
10.1136/bmj.322.7295.1179
BMJ 2001
Wald DS,Bishop L,Wald NJ,Law M,Hennessy E,Weir D,McPartlin J,Scott J Randomized trial of folic acid supplementation and serum homocysteine levels.. vol.161, (5) 695.
10.1001/archinte.161.5.695
Arch Intern Med 2001
Wald NJ,Hackshaw AK Folic acid and miscarriage: an unjustified link.. vol.98, (2) 204.
10.1002/1096-8628(20010115)98:2<204::AID-AJMG1032>3.0.CO;2-D
Am J Med Genet 2001
Wald NJ All screening is universal.. vol.8, (4) 169.
10.1136/jms.8.4.169
J Med Screen 2001
Wald NJ Folic acid and neural tube defects.. vol.volume, (55) 22.
doi
Bibl Nutr Dieta 2001
Wald NJ Guidance on terminology.. vol.8, (1) 56.
10.1136/jms.8.1.1
J Med Screen 2001
Wald NJ,LAW M,McPartlin J,Weir DG,Scott JM,Watt HC Homocysteine and coronary heart disease.. vol.volume, (issue) paginationBegin.
doi
journal 2001
Wald NJ,Harvey R JMS Online at a screen near you: www.jmedscreen.com. vol.8, (3) 113.
10.1136/jms.8.3.113
J MED SCREEN 2001
Hackshaw AK,Wald NJ,George LM Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defects.. vol.21, (1) 72.
10.1002/1097-0223(200101)21:1<72::AID-PD989>3.0.CO;2-T
Prenat Diagn 2001
Wald NJ,Morris JK Multiple marker second trimester serum screening for pre-eclampsia.. vol.8, (2) 65.
10.1136/jms.8.2.65
J Med Screen 2001
Hackshaw AK,Wald NJ Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.. vol.21, (1) 58.
10.1002/1097-0223(200101)21:1<58::AID-PD964>3.0.CO;2-9
Prenat Diagn 2001
Wald NJ The definition of screening.. vol.8, (1) 1.
10.1136/jms.8.1.1
J Med Screen 2001
Wald NJ,Law M The threat to the use of records and stored blood samples in medical screening research.. vol.8, (2) 58.
10.1136/jms.8.2.57a
J Med Screen 2001
SASSOON D ‘Conclusions’. vol.volume, (issue) 343.
10.1093/acprof:oso/9780192628268.003.0023
journal 2001
Ward DS,Bishop L,Wald NJ,Law M,Hennessey E,Weir D,McPartlin J,Scott J Randomised trial of folic acid on serum homocysteine levels in people with ischaemic heart disease. vol.102, (18) 869.
doi
CIRCULATION 2000
Hackshaw AK,Wald NJ Revised distribution parameters for serum markers for trisomy 18. vol.7, (4) 215.
10.1136/jms.7.4.215
J MED SCREEN 2000
WALD NJ,huttly WJ,bestwick JP,Old R,Morris JK,Cheng R,Aquilina J,Peregrine E,Roberts D,Alfirevic Z Prenatal reflex DNA screening for trisomy 21, 18, and 13. vol.volume, (issue) paginationBegin.
10.1038/gim.2017.188
Genetics in Medicine publicationYear
Wald NJ,Luteijn JM,Morris JK Starting the polypill: the use of a single age cut-off in males and females. vol.volume, (issue) paginationBegin.
10.1177/0969141316631578
Journal of Medical Screening publicationYear